22nd Century Group Reports Second Quarter 2025 Financial Results
1. 22nd Century expands VLN® brand partnerships, increasing market reach. 2. FDA supports VLN® products meeting new nicotine standards for tobacco. 3. Net revenues decreased sequentially to $4.1 million, overall losses stable. 4. Cigarette volumes rose significantly despite decreased net revenues. 5. Company aims for profitable growth phase with high-margin products.